期刊文献+

帕洛诺司琼对舒芬太尼胸腔镜术后镇痛期呕吐的防治 被引量:5

Post-operative nausea and vomiting prevention effect of palonosetron on thoracoscopy sufentanil analgesia
下载PDF
导出
摘要 目的探讨帕洛诺司琼对舒芬太尼胸腔镜术后镇痛期恶心呕吐的防治效果。方法将80例胸腔镜手术患者按照随机数字表法均分为观察组和对照组,2组患者麻醉方法相同,观察组于切皮前10min静脉注射帕洛诺司琼0.25mg,对照组切皮前10min静脉注射托烷司琼5mg,比较2组患者手术的一般情况、血流动力学变化及术后恶心呕吐(PONV)发生率。结果 2组患者手术时间、麻醉时间和镇痛药用量等比较,差异均无统计学意义;2组患者手术各时段平均动脉压(MAP)和心率(HR)的变化差异无统计学意义。2组患者术后视觉模拟疼痛(VAS)评分呈先升高后降低趋势,其中2组t2、t3、t4时VAS评分显著高于t1时段(P〈0.05),2组间术后各时段VAS评分比较,差异无统计学意义;2组患者t1-t4时PONV发生率逐渐升高,观察组t3、t4时PONV发生率显著低于对照组(P〈0.05),2组t1、t2时PONV发生率比较,差异无统计学意义(P〈0.05);2组患者不良反应发生率比较,差异无统计学意义(χ^2=2.222,P=0.136)。结论帕洛诺司琼和托烷司琼能够降低舒芬太尼胸腔镜术后镇痛期恶心呕吐的发生率,且不良反应发生率低;帕洛诺司琼对延迟性呕吐效果更明显。 Objective To explore the post-operative nausea and vomiting prevention effect of palonosetron on thoracoscopy sufentanil analgesia.Methods A total of 80 cases of thoracoscopy surgey patients treated in hospital from January 2015 to March 2016 were randomly divided into observation group 40 cases and control group 40 cases.The 2groups of patients were treated with same anesthesia method.The observation group were given intravenously palonosetron 0.25 mg before 10 min with anesthesia induction,while the control group were given intravenously tropisetron 5mg before 10 min with anesthesia induction.The general surgery information,hemodynamic changes and post-operative nausea and vomiting(PONV)incidence rates were compared between the 2groups.Results The 2groups of patients with operation time,anesthesia time,and analgesic dosage showd no statistical difference.The mean arterial pressure(MAP)and heart rate(HR)changes in each period of operation showed no significant difference.2groups of patients with postoperative visual analogue scale(VAS)score was first increased and then decreased,which in t2,t3,t4 period VAS score was significantly higher than that of t1period(P〈0.05),there was no significant difference in VAS scores between the 2groups.The incidence of PONV was gradually increased in t1 to t4period,observation group PONV rates was significantly lower than that in the control group in t3,t4period(P〈0.05).There was no significant difference in PONV rates in t1,t2 period between the 2groups(P〈0.05).There was no significant difference in the incidence of adverse reactions between the 2groups(χ^2=2.222,P=0.136).Conclusion Palonosetron and tropisetron can decrease the incidence of sufentanil thoracoscopy postoperative analgesia nausea and vomiting,with low incidence of adverse reactions.On delayed vomiting,palonosetron is better than tropisetron.
出处 《西北药学杂志》 CAS 2016年第6期616-619,共4页 Northwest Pharmaceutical Journal
基金 国家自然科学基金项目(编号:81100814)
关键词 帕洛诺司琼 托烷司琼 胸腔镜 恶心 呕吐 镇痛 palonosetron tropisetron thoracoscopy nausea vomiting analgesia
  • 相关文献

参考文献6

二级参考文献67

  • 1朱辉,朱楚琼,杨剑,李莲.舒芬太尼联合丙泊酚减轻无痛人流术后宫缩痛[J].湖北医药学院学报,2013,32(2):154-157. 被引量:16
  • 2吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 3陈艳,丁莉坤,孟玲燕,丁黎,杨林,文爱东.盐酸帕洛诺司琼注射液人体药动学研究[J].中国新药杂志,2007,16(10):806-809. 被引量:14
  • 4Yang LP,Scott LJ.Palonosetron:in the prevention of nausea and vomiting.Drugs,2009,69:2257-2278.
  • 5Navari RM.Antiemetic control:toward a new standard of care for emetogenic chemotherapy.Expert Opin Pharmacother,2009,10:629-644.
  • 6Gralla R,Liehinitser M,Van Der Vegt S,et al.Palonosetron improves prevention of chemotherapy-induced nausea and vomiting followingmoderatelyemetogeniechemotherapy:resultsofa double-blind randomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron.Ann Onco1,2003,14:1570-1577.
  • 7Lorusso V,Spedicato A,Petrucelli L,et al.Single dose of palonosetron plus dexamethasone to control nausea,vomiting and to warrant an adequate food intake in patients treated with highly emetogenic chemotherapy (HEC).Preliminary results.Support Care Cancer,2009,17:1469-1473.
  • 8Trotti A,Colevas AD,Setser A,et al.CTCAE v3.0:development of a comprehensive grading system for the adverse effects of cancer treatment.Semin Radiat Oncol,2003,13:176-181.
  • 9Aapro MS,Grunberg SM,Manikhas GM,et al.A phase Ⅲ,double-blind,randomized trial of palonosetron compared with ondansetroninpreventingchemotherapy-inducednauseaand vomiting following highly emetogenic chemotherapy.Ann Oncol,2006,17:1441 -1449.
  • 10Yu Z,Liu W,Wang L,et al.The efficacy and safety of palonosetroncomparedwithgranisetroninpreventinghighly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients:a phaseⅡ,multicenter,randomized,double-blind,parallel,comparative clinical triaLSupport Care Cancer,2009,17:99-102.

共引文献64

同被引文献43

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部